Vaxcyte, Inc.
PCVX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$464 | -$402 | -$223 | -$100 |
| Dep. & Amort. | $16 | $10 | $9 | $3 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $85 | $49 | $24 | $11 |
| Change in WC | -$55 | $81 | $13 | -$37 |
| Other Non-Cash | -$34 | -$35 | $7 | $2 |
| Operating Cash Flow | -$453 | -$297 | -$171 | -$121 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$22 | -$68 | -$6 | -$7 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$3,087 | -$1,330 | -$103 | -$336 |
| Inv. Sales/Matur. | $1,200 | $624 | $183 | $131 |
| Other Inv. Act. | -$97 | $0 | $0 | $0 |
| Investing Cash Flow | -$2,006 | -$773 | $75 | -$212 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $2,436 | $636 | $856 | $14 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $13 | $4 | $5 | $4 |
| Financing Cash Flow | $2,449 | $640 | $862 | $18 |
| Forex Effect | $0 | -$7 | $0 | -$0 |
| Net Chg. in Cash | -$9 | -$437 | $766 | -$316 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $399 | $836 | $70 | $386 |
| End Cash | $389 | $399 | $836 | $70 |
| Free Cash Flow | -$475 | -$365 | -$176 | -$128 |